← Eichor
Study identifier: NCT06983080 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)

Condition: Insomnia Chronic · Older People · Drug Therapy  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhasePhase 2
Planned participants40
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate how effective trazodone is in treating insomnia in adults aged 65 years and older. The main question it aims to answer is : \- Is trazodone more effective than a placebo in reducing the severity of insomnia symptoms in older adults? Participants will : * Take 25 to 50 mg of trazodone or a matching placebo before bed for 28 days. After a 2-week break, they will then take the other medication for another 28 days. * Visit the clinic three times for checkup and test * Complete a sleep diary and wear an actimeter during the night.

This description comes directly from the study's public registry record.

Talk to the study team

Patrick Nguyen, B. Pharm, M.Sc.  ·  514-890-8000  ·  patrick.nguyen.chum@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier de l'Université de MontréalMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06983080